FDA Drug recall D-0205-2019
Phentolamine 1 mg/Papaverine 15 mg/Alprostadil 150 mcg Aqueous Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1308-03
- FDA Drug
- Class II
- terminated
- Published 2018-11-07
On 2018-11-07 the FDA classified a Class II recall of Phentolamine 1 mg/Papaverine 15 mg/Alprostadil 150 mcg Aqueous Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1308-03 by Pharm D Solutions, citing lack of Assurance of Sterility.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0205-2019 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2018-09-10 |
| Published | 2018-11-07 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Pharm D Solutions |
| Distribution | US |
Product
Phentolamine 1 mg/Papaverine 15 mg/Alprostadil 150 mcg Aqueous Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1308-03
Reason
Lack of Assurance of Sterility
Identifiers
| code_info | Lot: 04102018:07 Discard by: 10/7/2018; 05102018:18 Discard by: 11/6/2018; 05222018:64 Discard by: 8/1/2018; 07022018:4…Lot: 04102018:07 Discard by: 10/7/2018; 05102018:18 Discard by: 11/6/2018; 05222018:64 Discard by: 8/1/2018; 07022018:46 Discard by: 12/29/2018; 08012018:81 Discard by: 1/28/2019; 06202018:97 Discard by: 9/17/2018 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0205-2019%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.